The EB Scientific Integrity Policy for Submission of Abstracts is based on recommendations from the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, the Council of Science Editors White Paper on Promoting Integrity in Scientific Journal Publications, and the US Department of Health and Human Services’ Office of Research Integrity.
EB host societies expect all authors to comply with generally accepted standards to avoid scientific misconduct. For more information, please see Scientific Misconduct.
All abstracts submitted to EB for possible publication and presentation at the conference will undergo a review process by the host societies prior to publication in The FASEB Journal
. (Please note: The FASEB Journal’s
editors and editorial board play no role in the review of EB abstracts, and the review of EB abstracts is the responsibility of the host societies.) The goal of abstract review is to be inclusive of quality science without compromising scientific integrity. Each host society has developed a procedure for reviewing abstracts and has the general authority to reject an abstract as part of the review process. Both authors and reviewers are expected to take their roles seriously, as detailed below. For information about the abstract review process, please see Reviewer Conduct.
General Authorship Guidelines. Authorship is defined as 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the abstract or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3. Submission of an abstract to EB constitutes a commitment by the author(s) to scientifically defend their work in the format (poster, oral presentation, or both) assigned by the host society. Failure to do so, if not justified, may result in a notice of retraction in The FASEB Journal
or may jeopardize future acceptance of abstracts.